文献速递腹部PETCT

双时间点2-[18F]FDG PET/CT影像组学模型鉴别胰腺导管腺癌与自身免疫性胰腺炎

Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis.
PubMed 文献 · Eur Radiol · 2021-03-06

本研究为回顾性研究,纳入112例患者(AIP 48例,PDAC 64例),从双时间点PET/CT图像提取502个影像组学特征及12个MIP特征,经SVM-RFE筛选和线性SVM建模,采用嵌套交叉验证评估。模型平均AUC 0.9668,准确率89.91%,敏感度85.31%,特异度96.04%,提示影像组学模型有潜力无创鉴别AIP与PDAC。

要点

  • 双时间点PET/CT影像组学模型鉴别PDAC与AIP的平均AUC达0.9668。
  • 模型平均敏感度85.31%、特异度96.04%,特异度较高。
  • PDAC与AIP临床症状及影像视觉表现高度相似,准确鉴别困难。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) and autoimmune pancreatitis (AIP) are diseases with a highly analogous visual presentation that are difficult to distinguish by imaging. The purpose of this research was to create a radiomics-based prediction model using dual-time PET/CT imaging for the noninvasive classification of PDAC and AIP lesions.

METHODS: This retrospective study was performed on 112 patients (48 patients with AIP and 64 patients with PDAC). All cases were confirmed by imaging and clinical follow-up, and/or pathology. A total of 502 radiomics features were extracted from the dual-time PET/CT images to develop a radiomics decision model. An additional 12 maximum intensity projection (MIP) features were also calculated to further improve the radiomics model. The optimal radiomics feature set was selected by support vector machine recursive feature elimination (SVM-RFE), and the final classifier was built using a linear SVM. The performance of the proposed dual-time model was evaluated using nested cross-validation for accuracy, sensitivity, specificity, and area under the curve (AUC).

RESULTS: The final prediction model was developed from a combination of the SVM-RFE and linear SVM with the required quantitative features. The multimodal and multidimensional features performed well for classification (average AUC: 0.9668, accuracy: 89.91%, sensitivity: 85.31%, specificity: 96.04%).

CONCLUSIONS: The radiomics model based on 2-[18F]fluoro-2-deoxy-D-glucose (2-[18F]FDG) PET/CT dual-time images provided promising performance for discriminating between patients with benign AIP and malignant PDAC lesions, which shows its potential for use as a diagnostic tool for clinical decision-making.

KEY POINTS: • The clinical symptoms and imaging visual presentations of PDAC and AIP are highly similar, and accurate differentiation of PDAC and AIP lesions is difficult. • Radiomics features provided a potential noninvasive method for differentiation of AIP from PDAC. • The diagnostic performance of the proposed radiomics model indicates its potential to assist doctors in making treatment decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Z, Li M, Zuo C, et al. Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis. Eur Radiol. 2021. PMID: 33677645. doi:10.1007/s00330-021-07778-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。